Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 33

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 33
---
 our existing securityholders could cause the price of our Common Stock and Warrants to fall. The securities being offered in this prospectus represent a substantial percentage of our outstanding shares of Common Stock and Warrants. Under this prospectus, the Selling Securityholder can resell up to total of 2,100,000 shares of Common Stock. Sales of a substantial number of shares of our Common Stock in the public market, including the resale of the shares held by the Selling Securityholder, could occur at any time (after the expiration of any applicable lock-up period, assuming the satisfaction of any applicable vesting conditions and subject to the beneficial ownership and stock exchange limitations described herein). These sales, or the perception in the market that the holders of a large number of shares of our Common Stock intend to sell shares, could increase the volatility of the market price of our Common Stock or result in a significant decline in the public trading price of our Common Stock. The shares of Common Stock being offered for resale pursuant to this prospectus by the Selling Securityholder represent approximately 8.2% of shares of fully-diluted Common Stock outstanding as of May 19, 2025, assuming and after giving effect to the issuance of Common Stock upon exercise of all outstanding Common Warrants and options and Preferred Warrants and the maximum number of shares of Common Stock issuable upon conversion of all outstanding Preferred Shares. After the registration statement of which this prospectus forms a part is effective and until such time that it is no longer effective, it will permit the resale of these shares of Common Stock. The resale, or expected or potential resale, of a substantial number of shares of our Common Stock in the public market could adversely affect the market price for our Common Stock and make it more difficult for you to sell your holdings at times and prices that you determine are appropriate. Furthermore, we expect that, because there is a large number of shares of our Common Stock being registered pursuant to the registration statement of which this prospectus forms a part, the Selling Securityholder thereunder will continue to offer the securities covered thereby for a significant period of time, the precise duration of which cannot be predicted. Accordingly, the adverse market and price pressures resulting from an offering pursuant to the registration statement may continue for an extended period of time. Sales of substantial number of such shares in the public market, including the resale of the shares of Common Stock held by the Selling Securityholder, could adversely affect the market price of our Common Stock. In addition to this prospectus, we have filed:

|